Cited by 232Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Treatment and Management

Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004

Ong, Kwok Leung, Cheung, Bernard M.Y., Wong, Louisa Y.F., Wat, Nelson M.S., Tan, Kathryn C.B., Lam, Karen S.L.·2008·Annals of Epidemiology

Abstract

Purpose This study aimed to examine the trends in prevalence, treatment, and control of diagnosed diabetes in United States adults 20 years of age or older.Methods Data from the National Health and Nutrition Examination Survey 1999-2004 were used. Glycemic, blood pressure, and total cholesterol target levels were defined as having glycosylated hemoglobin <7.0%, blood pressure <130/80 mm Hg, and total cholesterol <200 mg/dL, respectively.Results The prevalence of diagnosed diabetes was 7.8% in 2003-2004 and increased significantly in people aged 40-59 years, women, non-Hispanic whites, and obese people in the period 1999-2004. Although there was no significant change in the pattern of antidiabetic treatment, the age-adjusted percentage of people with diagnosed diabetes achieving glycemic and blood pressure target levels increased from 35.8% to 57.1% (p = 0.002) and from 35.7% to 48.3% (p = 0.04), respectively. However, there were only insignificant increases in percentages of those persons achieving total cholesterol target level (from 48.8% to 50.4%) and those achieving all 3 target levels (from 7.5% to 13.2%).Conclusions In 1999-2004, the prevalence of diagnosed diabetes increased significantly in some subgroups of the population. However, the increases in percentages of people with diabetes achieving glycemic and blood pressure targets are encouraging, although there is room for improvement.

Integrity signals

Registry

Crossref · 10.1016/j.annepidem.2007.10.007

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many racial/ethnic minority groups, particularly Blacks/African-Americans and Hispanics-Latinos, are at greater risk of obesity, heart disease, diabetes, and cardiovascular events.

    “In particular many racial/ethnic minority groups (particularly Blacks/African-Americans and Hispanics-Latinos) are at greater risk of obesity, heart disease, diabetes, and cardiovascular events (204, 206, 207).”
  • African-Americans and Mexican-Americans are at greater risk of developing diabetes compared to non-Hispanic whites.

    “African-Americans and Mexican-Americans are at greater risk of developing diabetes compared to non-Hispanic whites [3]”
  • Racial/ethnic and socioeconomic disparities exist in cardiometabolic diseases, with minority populations such as African Americans and Hispanics and those of lower socioeconomic status experiencing a greater burden.

    “Unfortunately, racial/ethnic and socioeconomic disparities in these diseases exist such that minority populations, such as African Americans and Hispanics, and those of lower socioeconomic status, experience a greater burden.”

Cites

1 retracted

Flagged first, then by citations

2 of the 35 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L.
Affiliations
University of Hong Kong (HK)
Corresponding author
Cheung, Bernard M.Y.
Venue
Annals of Epidemiology
Publisher
Elsevier BV
Published
2008-03
Volume
18
Issue
3
Pages
222-229
ISSN
1047-2797 (ISSN-L)
OpenAlex
W2029084557
Cited by
232
References
35
Citations by year
2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 21 · 2013: 21 · 2012: 22
FWCI
25.10
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diagnosed diabetes, diabetes prevalence, diabetes treatment, glycemic control, blood pressure control, cholesterol management, HbA1c, antidiabetic therapy, diabetes trends, obesity, sex differences, racial differences
MeSH terms
Adult, Aged, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Nutrition Surveys, Regression Analysis, United States, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review